PPP subsidy from Health~Holland

  • In October 2024, RegMed XB is awarded to be one of the selected programs by Health~Holland. This 3-year Public-Private Partnership (PPS) subsidy program, called 'Regenerative Medicine Translational Synergy' Will have reservations for €2 million in 2025, and reservations for the same amount in 2026 and 2027.

    About the program

    The program focuses on translational public-private partnership projects within the field of regenerative medicine, which enables consortia of businesses and research institutions to apply for funding to accelerate groundbreaking projects in the Life Sciences & Health sector. Through the programs, parties have the opportunity to jointly select and support PPP projects with the PPP subsidy from Health~Holland. 

    RegMed XB focuses on Regenerative Medicine (RG), a promising field with the potential to restore or replace damaged tissues and organs. Together with public and private partners, RegMed XB is developing ambitious moonshots to push forward RG solutions for significant patient needs. This program is not just transforming healthcare but also strengthening the economy through innovation and collaboration.

    Program coordinator

    RegMed XB: Renate de Cler (r.decler@regmedxb.com)

    Program group

    RegMed XB, The Dutch Diabetes Research Foundation, The Dutch Kidney Foundation, The Dutch Heart foundation, The Eye Foundation, TU/e, UMC Utrecht, LUMC, Maastricht University and HCM Medical
    NL HH